Day: March 1, 2021

Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates

Written by Customer Service on March 1, 2021. Posted in Earnings Releases And Operating Results.

2020 Total Galafold Revenue of $260.9M; Increased 43 Percent Year-on-YearContinued Strong Global Growth of Galafold Expected in 2021 with Revenue of $300M-$315MAT-GAA Rolling BLA Submission in Pompe Disease Planned for Completion in 2Q21 and Other Global Submissions Expected Throughout 2021CLN6 Batten Disease Gene Therapy Granted Fast Track Designation by U.S. FDACash Position Sufficient to Achieve Self-SustainabilityConference Call and Webcast Today at 8:30 a.m. ETPHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced financial results for the full year ended December 31, 2020.John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics,...

Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy

Written by Customer Service on March 1, 2021. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., March 01, 2021 (GLOBE NEWSWIRE) — Today, Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical stage biopharmaceutical company developing novel therapies for patients with classical complement-mediated disorders of the body, brain and eye, announced that patient dosing has begun in its Phase 2 ARCHER study of its anti-C1q therapy, ANX007, to treat Geographic Atrophy (GA). GA, also known as atrophic age-related macular degeneration (AMD) or dry AMD, can lead to blindness caused by damaged and dying retinal cells. Currently, there are no approved treatment options to prevent onset or progression of GA.“We are pleased to have commenced this important Phase 2 trial, advancing ANX007 as a potential therapy for GA, a leading cause of blindness and highly burdensome disease which affects more than five million...

CW Petroleum Corp (CWPE): Shareholder Update Announcing 2021 Business Plan

Written by Customer Service on March 1, 2021. Posted in Public Companies.

Katy, Texas, March 01, 2021 (GLOBE NEWSWIRE) — CW Petroleum Corp (OTCQB: CWPE), in a Shareholder Update, announce today an outline of the company’s 2021 busines plan for growth. The company’s growth plans include 4 strategic paths:First, the introduction of its Proprietary EPA approved Reformulated “No Ethanol” Gasoline into the North Eastern USA and Midwestern States.Second, the expansion of its Refined Products Trading across all USA Refined Products Pipelines it is currently approved to ship on.Third, the expansion of sales of Biodiesel, Renewable Diesel Fuel and Renewable Gasoline. As part of its “Green Renewable Fuels Program”.Fourth, the rapid acquisition of Convenience Stores so it can become a fully integrated oil company.For additional information, visit our website at cwpetroleumcorp.com or call 281-817-8099About CW Petroleum...

COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™

Written by Customer Service on March 1, 2021. Posted in Mergers And Acquisitions.

Pune, India, March 01, 2021 (GLOBE NEWSWIRE) — The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, Research Institutes, and Others), and Regional Forecast, 2020-2027”.Industry...

Kreditbanken A/S: Indberetningspligtiges transaktioner med aktier i Kreditbanken A/S

Written by Customer Service on March 1, 2021. Posted in Public Companies.

Kreditbanken A/S: Indberetningspligtiges transaktioner med aktier i Kreditbanken A/SVedhæftede filerMeddelelse 7 2021Meddelelse 8 2021

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2020

Written by Customer Service on March 1, 2021. Posted in Public Companies.

Announced positive preliminary results from Phase 1 SAD clinical trial of MORF-057AbbVie exercised license option to αvβ6 integrin inhibitor program for fibrotic diseasesExpanded research and development collaboration with Janssen through third integrin programConference call today at 8:00 a.m. ETWALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the full year 2020.2020 and Recent Corporate HighlightsFiled first IND of an oral integrin drug candidate, MORF-057, generated by Morphic’s MInT Platform and initiated first clinical study of MORF-057 in healthy volunteers in Phase 1 clinical trial of oral IBD candidate,...

Tyson Foods to Vaccinate Thousands of Iowa Workers

Written by Customer Service on March 1, 2021. Posted in Public Companies.

SPRINGDALE, Ark., March 01, 2021 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) will offer free, onsite COVID-19 vaccinations to thousands of frontline team members at its Iowa plants this week. The vaccines are being provided in conjunction with local health departments across the state of Iowa, where food processing workers are among the priority group now eligible for vaccination.“We’ve been working with Matrix Medical, Hy-Vee and health department officials across Iowa to prepare for this moment and we’re ready,” said Tom Brower, senior vice president of Health and Safety for Tyson Foods. “We’re pleased to offer our team members convenient access to the vaccine, and we appreciate the state of Iowa recognizing the essential role they play in feeding the world.”Tyson Foods officials expect many of the company’s 13,000 Iowa employees...

PLx Pharma Receives FDA Approval of SNDAs for Both VAZALORE 325 mg and 81 mg

Written by Customer Service on March 1, 2021. Posted in Public Companies.

— VAZALORE is the first ever liquid-filled aspirin capsule with an innovative delivery platform indicated as a pain reliever, fever reducer and for aspirin therapy in vascular indications –— U.S. commercial launch of VAZALORE planned for third quarter 2021 —SPARTA, N.J., March 01, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform designed to provide more effective and safer products. PLx announced today that the U.S. Food and Drug Administration (“FDA”) approved supplemental new drug applications (“sNDAs”) for its lead products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”), the first ever novel, liquid-filled aspirin...

Endeavour Silver Reports $19.9 Million Earnings in the Fourth Quarter, 2020 and $1.2 Million Earnings for the Full Year, 2020

Written by Customer Service on March 1, 2021. Posted in Public Companies.

Earnings Conference Call at 10am PST (1pm EST) TodayVANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (NYSE: EXK; TSX: EDR) released today its financial results for the fourth quarter and year ended December 31, 2020. The Company operates three silver-gold mines in Mexico: the Guanaceví mine in Durango state, the Bolañitos mine in Guanajuato state and the El Compas mine in Zacatecas state. All dollar ($) amounts are reported in United States dollars (US$).Bradford Cooke, Endeavour CEO, commented, “While 2019 was operationally the most challenging in our 16-year history as a producing company, 2020 was perhaps one of the most satisfying. Notwithstanding a government mandated two-month suspension of mining operations due to the COVID pandemic, we delivered higher production and lower costs at each...

INNSUITES HOSPITALITY TRUST (IHT) FISCAL SECOND QUARTER

Written by Customer Service on March 1, 2021. Posted in Public Companies.

Phoenix, AZ, March 01, 2021 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT)IHT CLEAN ENERGY DIVERSIFICATION PROGRESSInnSuites Hospitality Trust (IHT) reported fiscal 2021 second quarter revenues of approximately $1 million for the three months May 1, 2020 to July 31, 2020 compared to revenues of approximately $1.54 million for the same prior year period. Basic earnings per share for the three months ended July 31, 2020 was ($0.14) compared with ($0.05) for the three months ended July 31, 2019. This decline was largely attributable to the negative impact of the Covid-19 virus pandemic.In 2019, InnSuites Hospitality Trust (IHT) made an initial $1 million bond diversification investment convertible into 1 million shares of privately held UniGen Power, Inc. (UPI), a company developing a patented high profit potential...

Day: March 1, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals